NICE recommends Wegovy as part of a specialist weight management service for adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities
The effect is intentional for weight loss but can feel unpleasant during the adjustment phase
UK prescribers and patients now have substantial real-world experience with titration, injection technique, missed-dose rules, and follow-up, alongside the SURPASS trial programme that supported licensing
That single pharmacokinetic number explains almost everything about the dosing schedule: why injections happen once a week, why it takes 4 to 5 weeks to reach steady state at each dose level, and why the drug lingers for roughly 30 days after your last dose
However, pharmacodynamic considerations exist, including additive glucose-lowering effects and potential for increased dehydration risk, requiring careful clinical monitoring
Variations in antioxidant enzymes were also observed in many studies